- NEWS AND VIEWS
Fibroblast cells reveal their ancestry
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 593, 511-512 (2021)
doi: https://doi.org/10.1038/d41586-021-01204-7
References
Koliaraki, V., Prados, A., Armaka, M. & Kollias, G. Nature Immunol. 21, 974–982 (2020).
Davidson, S. et al. Nature Rev. Immunol. https://doi.org/10.1038/s41577-021-00540-z (2021).
Croft, A. P. et al. Nature 570, 246–251 (2019).
Buechler, M. B. et al. Nature 593, 575–579 (2021).
Gautier, E. L. et al. Nature Immunol. 13, 1118–1128 (2012).
Gosselin, D. et al. Cell 159, 1327–1340 (2014).
Lavin, Y. et al. Cell 159, 1312–1326 (2014).
Korsunsky, I. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.01.11.426253 (2021).
Competing Interests
The author has founder’s equity in Mestag Therapeutics, a company that that aims to discover, develop and deliver impactful precision medicines through targeting disease-driving fibroblast subpopulations.